MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 57 filers reported holding MUSTANG BIO INC in Q3 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -50.0% | 5,554 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -33.3% | 5,554 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | -40.0% | 5,554 | 0.0% | 0.00% | – |
| Q3 2021 | $15,000 | -16.7% | 5,554 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | 0.0% | 5,554 | +0.2% | 0.00% | – |
| Q1 2021 | $18,000 | -14.3% | 5,545 | 0.0% | 0.00% | – |
| Q4 2020 | $21,000 | +90.9% | 5,545 | +61.7% | 0.00% | – |
| Q3 2020 | $11,000 | -26.7% | 3,429 | -25.9% | 0.00% | – |
| Q2 2020 | $15,000 | +25.0% | 4,627 | +0.7% | 0.00% | – |
| Q1 2020 | $12,000 | -50.0% | 4,597 | -23.2% | 0.00% | – |
| Q4 2019 | $24,000 | +50.0% | 5,983 | +24.5% | 0.00% | – |
| Q3 2019 | $16,000 | -11.1% | 4,804 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | +125.0% | 4,804 | +94.3% | 0.00% | – |
| Q1 2019 | $8,000 | +14.3% | 2,472 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -53.3% | 2,472 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | -11.8% | 2,472 | 0.0% | 0.00% | – |
| Q2 2018 | $17,000 | – | 2,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,375,000 | $12,420,000 | 0.88% |
| FNY Investment Advisers, LLC | 200,000 | $736,000 | 0.22% |
| 683 Capital Management, LLC | 625,000 | $2,300,000 | 0.21% |
| HIGHLAND CAPITAL MANAGEMENT LP | 350,000 | $1,288,000 | 0.08% |
| B. Riley Wealth Advisors, Inc. | 107,874 | $397,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 176,400 | $650,000 | 0.02% |
| Quinn Opportunity Partners LLC | 35,514 | $131,000 | 0.02% |
| Frontier Wealth Management LLC | 29,510 | $109,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 15,031 | $55,000 | 0.01% |
| Alyeska Investment Group, L.P. | 165,811 | $610,000 | 0.01% |